from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3285/accA3

LFCtreatmentdescriptionclass of inhibitor

-2.270

Amikacinug/mL Amikacintranslation

-1.577

Cap5-10ug/mL Capreomycintranslation

-1.399

Rox10-50 ug/mL Roxithromycintranslation

0.056

SM2-5 ug/mL Streptomycintranslation

-3.165

Tet5-10 ug/mL Tetracyclinetranslation

-1.622

Rif0.2-5ug/mL Rifampicintranscription

-1.334

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.359

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.744

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.054

CPZ10-50 ug/mL Chlorpromazinerespiration

0.251

Clofazimine10-13 ug/mL Clofaziminerespiration

0.175

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.921

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.611

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.853

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.249

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.083

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.340

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.195

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.648

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.219

KCN5-20 ug/mL Potassium cyaniderespiration

0.634

NaN30.2-2 mM Sodium aziderespiration

0.673

Nigericin50 uM Nigericinrespiration

-1.234

TRC10-150 ug/mL Triclosanrespiration

-0.190

TRZ10-25 ug/mL Thioridazinerespiration

-1.259

Valinomycin0.5-10 uM Valinomycinrespiration

0.663

ZnSO42 mM ZnSO4respiration

0.531

menadione6-10 ug/mL Menadionerespiration

-0.167

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.602

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.130

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.662

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.105

NRP_1Non-replicating persistence stage 1dosRassociated

0.546

Amp0.2mg/mL AmpicillincellWall

0.195

Cephalexin20-100 ug/mL CephalexincellWall

1.539

Cerulenin0.32-5 ug/mL CerulenincellWall

0.719

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.711

EMB10-20 ug/mL EthambutolcellWall

2.152

Eta12-40 ug/mL EthionamidecellWall

2.277

INH0.2-0.4 ug/mL IsoniazidcellWall

1.716

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.021

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.356

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.572

BZA0.12 mg/mL BenzamidearomaticAmides

-0.453

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.535

H2O24 mM hydrogen peroxideDNAdamaging

0.421

Levo10 ug/mL LevofloxacinDNAdamaging

0.448

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.418

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.773

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.502

UVUV-irradiationDNAdamaging

-0.952

ARP41-4 ug/mL Antitubercular compound ARP4?

0.105

Antimycin12.5-50 ug/mL Antimycin A?

0.472

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.357

PA_110-50 ug/mL Antitubercular compound PA-1?

0.412

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.922

PA8240.2-2 ug/mL PA-824?

0.327

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.249

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.074

Verapamil50 uM Verapamil?

0.536

mercaptoethanol2 mM 2-Mercaptoethanol?

0.667

methoxatin10-20 ug/mL Methoxatin?